INTRODUCTION OF NINGBO LIWAH PHARMACEUTICAL CO., LTD
Ningbo Liwah Pharmaceutical Co.,Ltd. is a leading comprehensive manufacturer with GMP Certificates in pharmaceutical industry and plant extract in china. We have great advantage in using natural plants as raw material adopting modern high technology combined with knowledge of traditional herbal medicines and phytochemistry , provides superior natural products and high-level technical services for industries in the fields of Pharmaceuticals, food supplements (nutraceutical), food additives and healthcare ingredients。

Ningbo liwah pharmaceutical Co., Ltd
Ningbo Liwah pharmaceutical Co., Ltd is pharmaceuticals manufacturer with long histroy, founded at 1958,original LIWAH is Ningbo traditional chinese medicine Company ,engaged in pharmaceutical manufacturing over more than 50 years.
Merged by HONGKONG Liwah trading Co., Ltd at 1993 after getting the ningbo governmental entities’s approval. With foreign investment and advanced facility launch into company,LIWAH become a foreign-national joint venture holding control corporation。
LIWAH was acquired by POINT KIN INTERNATIONAL LIMITED at 2005,now as a branch company wholly owned by oversea investment,registered capital RMB 135 M。Ningbo liwah pharmaceutical Co., Ltd have many professional employee who have rich work experience in pharmaceutical industry field,it’s the biggest Chinese patent medicine manufacturer in Ningbo city.
LIWAH PHARMA preparation base I
·located: Xinlian village,Yinzhou Dist.(Gaoqiao industry zone), Ningbo City 315174. Zhejiang province, China
· Area: 43000 square meter
· Qualification : GMP certificated by FDA at 2003
CERTIFICATE OF GOOD MANUFACTURING PRACTICES
FOR PHARMACEUTICAL PRODUCTS
Certificate NO.:浙 J0615
· Reputation : National high technology enterprise
Preparation formulation with GMP:tablet、granule, cream, hard capsule, powder, orally solution, orally disintegrating tablet…(including all the raw material and plant pre-treatment and plant extract process) ;
Ningbo Liwah pharm has the CHINESE DRUG Approval Number of 银杏叶片YIN XING YE PIAN ( English name: GINKGO Biloba leave extract tablet) is Z20027950 and we manufacture the Ginkgo biloba leaves extract powder as the raw material of YIN XING YE PIAN ,all the pre-treatment and plant extract process are finished on the GMP production line under the GMP control.
Liwah’s Ginkgo Biloba leaves extract have good reputation
in oversea market these years and were exported to
Europe( Belgium, france, spain),Japan ,Canada ,U.S.A. and Korean etc in worldwide.
Preparation formulation: tablet(thin film) Z20027950
YIN XING YE PIAN Issued date: 2002-11-30
GINKGO Biloba leave extract tablet Information source: http://www.sfda.gov.cn

Ningbo liwah pharmaceutical Co., Ltd
Ningbo Liwah pharmaceutical Co., Ltd is pharmaceuticals manufacturer with long histroy, founded at 1958,original LIWAH is Ningbo traditional chinese medicine Company ,engaged in pharmaceutical manufacturing over more than 50 years.
Merged by HONGKONG Liwah trading Co., Ltd at 1993 after getting the ningbo governmental entities’s approval. With foreign investment and advanced facility launch into company,LIWAH become a foreign-national joint venture holding control corporation。
LIWAH was acquired by POINT KIN INTERNATIONAL LIMITED at 2005,now as a branch company wholly owned by oversea investment,registered capital RMB 135 M。Ningbo liwah pharmaceutical Co., Ltd have many professional employee who have rich work experience in pharmaceutical industry field,it’s the biggest Chinese patent medicine manufacturer in Ningbo city.
LIWAH PHARMA preparation base I
·located: Xinlian village,Yinzhou Dist.(Gaoqiao industry zone), Ningbo City 315174. Zhejiang province, China
· Area: 43000 square meter
· Qualification : GMP certificated by FDA at 2003
CERTIFICATE OF GOOD MANUFACTURING PRACTICES
FOR PHARMACEUTICAL PRODUCTS
Certificate NO.:浙 J0615
· Reputation : National high technology enterprise
Preparation formulation with GMP:tablet、granule, cream, hard capsule, powder, orally solution, orally disintegrating tablet…(including all the raw material and plant pre-treatment and plant extract process) ;
Ningbo Liwah pharm has the CHINESE DRUG Approval Number of 银杏叶片YIN XING YE PIAN ( English name: GINKGO Biloba leave extract tablet) is Z20027950 and we manufacture the Ginkgo biloba leaves extract powder as the raw material of YIN XING YE PIAN ,all the pre-treatment and plant extract process are finished on the GMP production line under the GMP control.
Liwah’s Ginkgo Biloba leaves extract have good reputation
in oversea market these years and were exported to
Europe( Belgium, france, spain),Japan ,Canada ,U.S.A. and Korean etc in worldwide.
Preparation formulation: tablet(thin film) Z20027950
YIN XING YE PIAN Issued date: 2002-11-30
GINKGO Biloba leave extract tablet Information source: http://www.sfda.gov.cn

Ningbo liwah pharmaceutical Co., Ltd
Ningbo Liwah pharmaceutical Co., Ltd is pharmaceuticals manufacturer with long histroy, founded at 1958,original LIWAH is Ningbo traditional chinese medicine Company ,engaged in pharmaceutical manufacturing over more than 50 years.
Merged by HONGKONG Liwah trading Co., Ltd at 1993 after getting the ningbo governmental entities’s approval. With foreign investment and advanced facility launch into company,LIWAH become a foreign-national joint venture holding control corporation。
LIWAH was acquired by POINT KIN INTERNATIONAL LIMITED at 2005,now as a branch company wholly owned by oversea investment,registered capital RMB 135 M。Ningbo liwah pharmaceutical Co., Ltd have many professional employee who have rich work experience in pharmaceutical industry field,it’s the biggest Chinese patent medicine manufacturer in Ningbo city.
LIWAH PHARMA preparation base I
·located: Xinlian village,Yinzhou Dist.(Gaoqiao industry zone), Ningbo City 315174. Zhejiang province, China
· Area: 43000 square meter
· Qualification : GMP certificated by FDA at 2003
CERTIFICATE OF GOOD MANUFACTURING PRACTICES
FOR PHARMACEUTICAL PRODUCTS
Certificate NO.:浙 J0615
· Reputation : National high technology enterprise
Preparation formulation with GMP:tablet、granule, cream, hard capsule, powder, orally solution, orally disintegrating tablet…(including all the raw material and plant pre-treatment and plant extract process) ;
Ningbo Liwah pharm has the CHINESE DRUG Approval Number of 银杏叶片YIN XING YE PIAN ( English name: GINKGO Biloba leave extract tablet) is Z20027950 and we manufacture the Ginkgo biloba leaves extract powder as the raw material of YIN XING YE PIAN ,all the pre-treatment and plant extract process are finished on the GMP production line under the GMP control.
Liwah’s Ginkgo Biloba leaves extract have good reputation
in oversea market these years and were exported to
Europe( Belgium, france, spain),Japan ,Canada ,U.S.A. and Korean etc in worldwide.
Preparation formulation: tablet(thin film) Z20027950
YIN XING YE PIAN Issued date: 2002-11-30
GINKGO Biloba leave extract tablet Information source: http://www.sfda.gov.cn
·Representative product: PA FULIN :total paeonia lactiflora capsule
Liwah Pharma manufacturing base II
Invested by Ningbo liwah pharmaceutical Co., Ltd at 2006 with RMB 30M.Equipped with international standard production line, special engaged in plant extraction and all the raw material producing used for inhouse preparation formulation .
·located:NO.899,Fengming Rd,Xiepu Town(Ningbo industry zone) ,zhenhai Dist ,Ningbo City 315204. Area: 23000 sq.m.
·Qualification : GMP certificated by SFDA 2007(CHINA);
CERTIFICATE OF GOOD MANUFACTURING PRACTICES
FOR PHARMACEUTICAL PRODUCTS
Certificate NO.:浙 J0521
·NSF(CGMP ) 2009 ; ISO14001:2004; National high technology enterprise
·Preparation type:Bulk ; API;
·Single & compound formula granule; plant& herb extract
·Active Pharmaceutical Ingredients approval: Paeoniflorin、Huperzine-A、Capsaicin
·Scope of inspection: Bulk drug (Total Glucosides of paeony, Huperzine-A , Capsaicin) including plant pre-treatment and plant extract.
Production
Benefited from the enterprise's long history and experience, Liwah gains much technological advantage in P.E. industry.
Liwah has a first-phase construction of 5600 square meters where situated a purified workshop covering 400 square meters and has a second-phase construction in the process of construction . In the first-phase construction we have Extraction Workshop and Pharmaceutical Ingredient workshop, equipped with 10 multi-functional extractors, 2 high-velocity centrifuges, 6 single/bi-effect external-circulation concentrators, 4 sphere-concentrators, large spray-dryer , chromatography columns and other equipments etc.
Quality Management
The quality inspection area covers 372 square meters and owns chemical measurement room, standard solution room, weighing room, precision instrument room, traditional Chinese medicine identification room, reserved sample room, bacteria inspection preparation room, bacteria inspection room, drying room, and quality inspection office etc, equipped with advanced testing instruments and equipment such as 1 1200 HPLC of Agilent, 3 Shimadzu HPLC, 1 Shimadzu UV spectrophotometers, 1 GC, and 1 TLC scanner, which can completely meet the needs of production inspection.
Liwah has also improved its quality assurance system and quality management system in accordance with GMP requirements to control the whole process of product quality formation, to ensure the effectiveness of quality assurance and quality inspection, and to ensure the stability of product quality.
NINGBO LIWAH PHARMACEUTICAL CO., LTD




- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year

